Search results
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 5 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
Everything Congress SHOULD HAVE Asked Fauci About COVID-19 | News Talk 99.5 WRNO | The Glenn Beck...
iHeartRadio· 24 hours agoWith Dr. Fauci testifying before a House subcommittee on the origins of COVID-19, many thought he...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 19 hours agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 4 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...
US approves Moderna’s RSV vaccine for older adults | FOX 28 Spokane
FOX 28 Spokane· 4 days agoThe US Food and Drug Administration on Friday approved Moderna’s respiratory syncytial virus (RSV)...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 3 days agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 5 days agoModerna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine,...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KOMU Columbia· 2 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Moderna Could Pull Back Even More as Traders Nail Down Profits
TheStreet.com· 6 days agoModerna Could Pull Back Even More as Traders Nail Down Profits